IMPLEMENTATION LEVEL

NFI

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

Yes

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

firm-specific

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 14 Apr 2016 | Removal date: 14 Apr 2019
Still in force

State loan

On 14 April 2016, the Brazilian Company of Innovation and Research (FINEP) announced the approval of BRL 100.9 million (USD 28.8 million) loan allocated to the local pharmaceutical company EMS S.A. The objective of these resources is to finance the research, development and innovation program of the company.

The repayment deadline for the credit has been set up on 14 April 2019.


FINEP lending
The resources enclosed on the programs managed by FINEP are limited to Brazilian companies and seek to boost the national and international competitiveness of these businesses.

The interest rates set on the credit lines are composed of the long-term interest rate (TJLP) plus a supplement ranging between 1.5% and 7%, depending on the credit line and the repayment period.

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

352 Pharmaceutical products

Please report this page in case you detect an inaccuracy in its content.